Spironolactone
- Product NDC
- 71610-102
- Requested package NDC
- 71610-102-60
- 11-digit product format
- 716100102
- Labeler code
- 71610
- Product ID
- 71610-102_c9e366cc-e9b4-4e14-8c40-8daf2fe265ad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Spironolactone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA091426
- Marketing category
- ANDA
- Marketing start
- 2010-08-02
- Substance
- SPIRONOLACTONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091426-001 | SPIRONOLACTONE | SPIRONOLACTONE | 25MG | TABLET / ORAL | AB | 2010-07-02 | |
| A091426-002 | SPIRONOLACTONE | SPIRONOLACTONE | 50MG | TABLET / ORAL | AB | 2010-07-02 | |
| A091426-003 | SPIRONOLACTONE | SPIRONOLACTONE | 100MG | TABLET / ORAL | AB | 2010-07-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091426-001 | AB |
| A091426-002 | AB |
| A091426-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091426-001 | SPIRONOLACTONE | 25MG | TABLET / ORAL | AB | 2010-07-02 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091426-002 | SPIRONOLACTONE | 50MG | TABLET / ORAL | AB | 2010-07-02 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091426-003 | SPIRONOLACTONE | 100MG | TABLET / ORAL | AB | 2010-07-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091426-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091426-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091426-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Spironolactone | SPIRONOLACTONE | Bryant Ranch Prepack | 31aeab13-8f71-49f1-b101-8b0abb21b0dc | 2026-06-01 | Warnings, Adverse reactions | 091426 ANDA091426 |
| Spironolactone | SPIRONOLACTONE | QPharma, Inc | eb314e91-6dd5-4bdb-af35-5d147b20339c | 2026-05-11 | Warnings, Adverse reactions | 091426 ANDA091426 |
| Spironolactone | SPIRONOLACTONE | Amneal Pharmaceuticals of New York LLC | 951b8948-dc0f-4aef-9910-82c252de936d | 2025-12-16 | Warnings, Adverse reactions | 091426 ANDA091426 |
| Spironolactone | SPIRONOLACTONE | PharmPak, Inc. | c450e66a-0f05-445e-b1df-df2b17a2f064 | 2022-10-14 | Warnings, Adverse reactions | 091426 ANDA091426 |
| Spironolactone | SPIRONOLACTONE | Amneal Pharmaceuticals LLC | fb66327e-8261-46ae-b39a-4fa79d520844 | 2020-11-30 | Warnings, Adverse reactions | 091426 ANDA091426 |
| Spironolactone | SPIRONOLACTONE | Aphena Pharma Solutions - Tennessee, LLC | bf58378f-8304-4799-b0c0-fad8697149ab | 2018-08-08 | Warnings, Adverse reactions | 091426 ANDA091426 71610-102-60 71610-102 71610010260 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Spironolactone
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SPIRONOLACTONE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 27O7W4T232 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 313096 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| bf58378f-8304-4799-b0c0-fad8697149ab | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d335cba1-5b36-51c8-120a-594ec9d05330 | Product name | 5 | 20251114 |
| 25f5e2cf-3572-477b-994c-aa692751e5a8 | Product name | 2 | 20250616 |
| f151007d-265d-9fbe-857d-1d44f1cb76ba | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71610-102-60 | Spironolactone | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71610-102-60 | EA - Each | 71610-102 | b0a0c63f-ff7c-4d9e-afaf-5df13844e307 | 1 | 2018-10-11 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313096 | spironolactone 25 MG Oral Tablet | PSN | bf58378f-8304-4799-b0c0-fad8697149ab | 1 |
| 313096 | spironolactone 25 MG Oral Tablet | SCD | bf58378f-8304-4799-b0c0-fad8697149ab | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71610-102-60 | 71610010260 | 90 TABLET in 1 BOTTLE (71610-102-60) | 90 tablet | 2018-07-26 | 0000-00-00 | No | No | Current |